Pharmacy Daily | Bowel Cancer

Bowel cancer is the second most common cause of cancer related deaths in Australia, claiming over 70 lives each week. While it kills more Australians each year than breast or prostate cancer, with early detection through bowel screening programs, it can vastly improved survival rates. BowelScreen AustraliaTM is a pharmacy based bowel cancer awareness, education and screening program for the Australian community using a clinically proven, sensitive and reliable immunochemical faecal occult blood test. It is a collaboration between Bowel Cancer Australia and the Pharmacy Guild of Australia, with the support of Enterix Australia*. You, as the most accessible health care provider, are ideally placed to take an active role in the delivery of preventative health and are strongly encouraged to participate in this important screening program. Annual bowel cancer screening is recommended for Average Risk Patients. These include men and women: • 50 years and over • With no symptoms • With no personal or family history of bowel cancer or polyps BowelScreen AustraliaTM will be launched nationally on 4 June 2010 in anticipation of the Bowel Cancer Awareness Week 6 - 13 June. To help prepare for this launch and to deliver this important program in your pharmacy, order your BowelScreen AustraliaTM screening test kits by phoning Susan Zheng on 02 9887 5335 or email her at Susan.Zheng@enterix.com.au. *Manufacturer and accredited pathology lab for the InSure® immunochemical test

---

The above article was sent to subscribers in Pharmacy Daily's issue from 18 May 10
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 18 May 10